Serological typing of group B streptococci is important for the epidemiological study of group B streptococcal infections. These days, non typable (NT) strains by conventional serotypes were on an increase.
Introduction
Group B streptococcus is one of the most threatening pathogens to human beings, especially newborn babies. In Japan, initial reports of sepsis or meningitis caused by group B streptococci were published in 19761)2), after which research with serotyping was strated in order to investigate the etiology of infection on newborns. Murai et al.3> reported the type distribution of group B streptococci isolated from clinical materials in 1980. In contrast to these results, the number of non typable (NT) strains, that cannot be typed using conventional varieties of sera, seem to be increasing these days.
In 1984, strain designated as "M9" was isolated; it seemed to be a group B streptococci which had new polysaccharide antigen different from the types already known. This report deals with the definitive discription of antigen analysis of strain "M9" and the prevalence of group B streptococci having the same polysaccharide antigen as strain "M9", which is tentatively referred to as strain "M9" or antigen "M9" in this report, after the short reports previously presented in several meetings.
Materials and Methods
Strain "M9": Strain "M9" was originally isolated from the vaginal swabs of a pregnant woman in the carrier state, without any infectious symptoms of streptococcosis, during the 40th week of pregnancy in Meijo Hospital, Nagoya City. She had suffered from candidosis in the 31st week of pregnancy, and a group B streptococcus whose serotype seemed to be the same as that of "M9" had been isolated, together with Candida, at the 36th week. Her delivery was normal and the baby suffered no infections. At the first trial of typing by agglutination method4), this streptococcus was found to be NT, using the commercial antisera, type Ia, Ib, II, III, c, R and X (Denka Seiken Co. Ltd).
Anti "M9" serum: Rabbit serum hyperimmune against strain "M9" was prepared according to Jelinkova's method5).
Reference group B streptococcus strains: Reference strains for the preparation of reference extracts or absorption antigens were provided by the WHO Collaborating Center for Reference and Research, Czechoslovakia, and kept in Toho University. Strains supplied in this report were as follows: Type Ia "090" , Ib "R 36 B", II "18 RS 21", III "6313", IV "3139", V "SS1169", type candidate NT6, type candidate 7271, Ic "A 909", R "Compton", X "Compton", and group B "090 R".
Typing sera for precipitation reaction: Antisera against the reference strains for typing were prepared in Toho University, following by Jelinkova's method5>, and those characteristics had been tested by the WHO Collaborating Center, Czechoslovakia. The typing sera used in this investigation were as follows: Precipitation reaction: As the antigen for the precipitation reaction, extract was prepared by modified Lancefield's method, using 1/5 HC1 and incubating the suspension at 52C for 2 hours . Precipitation reaction by capillary tube was undertaken in routine typing, but in some of the experiments , reaction by micro gel6) was examined in addition to the capillary method.
Cross-absorption reaction: For absorption antigens, packed cells of reference strains were used at the rate of 1 g of cells wet weight per 1 ml of serum. The mixture of cells and serum was incubated at room temperature for 30 minutes and, after centrifugation, the existance of precipitin in the supernatant was examined.
Group B streptococci isolated in Meijo Hospital: A total of 152 group B streptococcal isolates from pregnant women were studied in this report. These strains were isolated in this Hospital during 1984 to 1987, the total number of isolates during this period being 415 strains. Out of them , 151 strains (33.5%) were found to be NT using the conventional typing sera for agglutination.
Group B streptococci isolated from clinical materials in the collection: Strains from clinical materials , including strains from sepsis and/or meningitis, have been collected in Toho University from 1975 until 1988. 157 strains (13.8%) out of the total of 1138 could not be typed serologically using the conventional nor provisional typing sera against polysaccharide antigens Ia, Ib, II, III, IV, V, type cand. NT6, and type cand. 7271.
Results
Precipitation reaction of strain "M9", type cand. NT6, and type cand. 7271: Table 1 shows the precipitation reaction of strains "M9", type cand. NT6, and type cand. 7271 against conventional or previsional typing sera. It was confirmed that strain "M9" did not react with these sera. Table 2 Procedure for the preparation of and"M9"typing serum
Characteristics of and "M9" serum: "M9" typing serum was prepared from crude serum by absorption with the absorption antigens which showed the cross precipitation reaction shown in Table 2 . After these procedures, the serum showed cross-reaction against neither conventional nor provisional types of polysaccharide. It did not react to any types of protein.
Cross-absorption reaction among antigens, "M9", type cand. NT6, and type cand. 7271: Cross absorption reaction among three antigens, "M9", and two type candidate antigens, was conducted using typing sera against each antigen. Table 3 shows that cross-absorption was not successful and that there was no relationship in polysaccharide antigens of these three types.
The prevalence of so-called type "M9" group B streptococci in pregnant women at Meijo Hospital: Table 4 shows the type distribution of group B streptococci isolated from vaginal swabs of the pregnant subjects, with special reference to NT strains by conventional typing sera. Out of 77 strains, 40 were typable with "M9" typing serum. Table 5 shows the type distribution of strains supplied to test the specificity of "M9" typing serum. No precipitation reaction was observed between "M9" typing serum and any of the 65 strains already identified as conventional types.
The prevalence of strains, so-called "M9", in clinical materials in Japan: NT strains of group B streptococci in our collection were attempted to be typed using "M9" typing serum. Out of 137 strains which had been identified as NT by conventional sera for precipitation, 40 (29.2%) reacted against "M9" typing serum. There were two kinds of combination of antigenic components. One consisted of the polysaccharide antigen "M9" only, and the other consisted of "M9" and protein "R" antigen. A total of 23 strains were the former, with the latter numbering 17, and thus annual trends of detection of "M9" strains could be calculated as shown in Table 6 . The first case of this type in our collection was seen in 1979. Table  7 shows the details of patients with group B streptococcal infection from whom strain "M9" was isolated. Table 4 New type distribution of group B streptococci having been identified as NT by conventional sera with old nomenclature note: All of the strains were isolated from pregnant women in the carrier state at Meijo Hospital, Nagoya City. There were seven cases of sepsis on newborn babies, three of which died. Geographical distribution was not clear, because of the geographical bias of the patients. But seven of 40 strains shown in Table 6 were isolated in the places other than Nagoya City. 
Discussion
It seems that type identification of group B streptococci is important, not only for the purpose of epidemiological surveys, but also for estimation and prediction of outbreaks of severe group B streptococcal infections among newborn babies. Historically, the group B streptococcus was thought to be primarily a pathogenic agent among cattle7), until there appeared a few reports of infection of this pathogen in human being in 19558). Subsequently the role of group B streptococci in human infection grew extensively in the decade of the 1970's9)10)11)12).
In Japan, a type distribution of group B streptococci isolated from clinical materials was published in 1980, including the results that 1.3% of the isolates were NT using typing sera with the old nomenclature: type Ia, Ib, II, III, Ic, R and X3). In 1984, Ooguro described the type distribution of strains isolated from patients with sepsis and/or meningitis during the period from 1976 to 1982; 4% of them were NT13). After the publication of this report, many clinical materials were identified in Toho University, using the conventional typing sera, and it sometimes happened that NT strains were isolated from even severe infections.
Subsequently, a new proposed nomenclaturel4)15) was dicided upon and two polysaccharide antigens (type IV and V) were introduced for worldwide use16). Now, additional two antigens exist as type candidate strains, namely NT6 and 7271, and research on these types is in progress under the leadership of the WHO Collaborating Center17). In this study, the new antigenicity of strain "M9", which is different from the conventional polysaccharide type antigens, is confirmed, as shown in Table 1 and 2, using the technique of precipitation and precipitation absorption reaction. Strain "M9" was primarily isolated from subjects in the carrier state. But afterwards, strains typed as "M9" were isolated even from patients with sepsis or meningitis as shown in Table 6 and 7. It seems that these results were strongly suggesting the pathogenicity of the strain typed as "M9".
After the re-typing of NT strains in our clinical collection from 1975, the first strain which was typed as "M9" could be found in 1979, and it came from Chiba Municipal Hospital. The second one was in the same year, coming from Kyoto Municipal Hospital. The geographicality of our collection has a large bias because of localization of the collaborators. Just now, we cannot draw any conclusions regarding geographical prevalence, but it seems true that the prevalence of strain "M9" is not necessarily located in Nagoya City, where this type was originally discovered.
The combination of antigens between polysaccharide and protein is sometimes useful for epidemiological purposes, to assure the identification of an infectious agent. It is clear that certain types of polysaccharide antigen like to combine with specified protein antigens, for example Ia/c, Ib/c, III/R, and IV/c. This phenomenon on occasion helps us make sure of our typing results; in this study in was observed that strains typed as "M9" well accompanied by protein "R" antigen, and no other protein .
Conclusion
So-called "M9" strain and polysaccharide "M9" antigen were studied in this report. The conclusions were as follows:
1) It was confirmed that strain "M9" had a new polysaccharide antigen, different from conventional types, Ia, Ib, II, III, IV and V, type candidate NT6 and type candidate 7271 , as found by precipitation and precipitation absorption reaction.
2) Group B streptococci typed as "M9" were isolated not only from carriers but from newborn babies suffering from sepsis.
3) Type "M9" strains were discovered in the clinical collections isolated in 1979 at Chiba or Kyoto , and this type was not necessarily located in Nagoya City.
4) It was observed that polysaccharide "M9" liked to combine with protein "R" and without other proteins, as far as our collection extends.
